Xue Guan

Dalian, 110042, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

In situ coagulation environment regulation-assisted thrombus clearance via hydrogenated silicon-based nanothrombolytics.

In situ coagulation environment regulation-assisted thrombus clearance via hydrogenated silicon-based nanothrombolytics.

Journal: Science advances

Published: February 06, 2026

pH-responsive 2D niobium carbide nanosheets for targeted circPUM1 siRNA delivery in ovarian cancer therapy.

pH-responsive 2D niobium carbide nanosheets for targeted circPUM1 siRNA delivery in ovarian cancer therapy.

Journal: Materials today. Bio

Published: June 26, 2025

Lactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancer.

Lactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancer.

Journal: Molecular cancer

Published: September 24, 2024

piRNA28846 has the potential to be a novel RNA nucleic acid drug for ovarian cancer.

piRNA28846 has the potential to be a novel RNA nucleic acid drug for ovarian cancer.

Journal: NPJ precision oncology

Published: January 16, 2024

CircCRIM1 promotes ovarian cancer progression by working as ceRNAs of CRIM1 and targeting miR-383-5p/ZEB2 axis.

CircCRIM1 promotes ovarian cancer progression by working as ceRNAs of CRIM1 and targeting miR-383-5p/ZEB2 axis.

Journal: Reproductive biology and endocrinology : RB&E

Published: August 08, 2021

CircRNA WHSC1 targets the miR-646/NPM1 pathway to promote the development of endometrial cancer.

CircRNA WHSC1 targets the miR-646/NPM1 pathway to promote the development of endometrial cancer.

Journal: Journal of cellular and molecular medicine

Published: July 09, 2019

CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182.

CircWHSC1 promotes ovarian cancer progression by regulating MUC1 and hTERT through sponging miR-145 and miR-1182.

Journal: Journal of experimental & clinical cancer research : CR

Published: May 26, 2019

CircRhoC promotes tumorigenicity and progression in ovarian cancer by functioning as a miR-302e sponge to positively regulate VEGFA.

CircRhoC promotes tumorigenicity and progression in ovarian cancer by functioning as a miR-302e sponge to positively regulate VEGFA.

Journal: Journal of cellular and molecular medicine

Published: March 08, 2019

circPUM1 Promotes Tumorigenesis and Progression of Ovarian Cancer by Sponging miR-615-5p and miR-6753-5p.

circPUM1 Promotes Tumorigenesis and Progression of Ovarian Cancer by Sponging miR-615-5p and miR-6753-5p.

Journal: Molecular therapy. Nucleic acids

Published: November 07, 2018

PUM1 promotes ovarian cancer proliferation, migration and invasion.

PUM1 promotes ovarian cancer proliferation, migration and invasion.

Journal: Biochemical and biophysical research communications

Published: January 26, 2018

LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1.

LncRNA ABHD11-AS1 promotes the development of endometrial carcinoma by targeting cyclin D1.

Journal: Journal of cellular and molecular medicine

Published: October 23, 2017

LncRNA PCGEM1 Induces Ovarian Carcinoma Tumorigenesis and Progression Through RhoA Pathway.

LncRNA PCGEM1 Induces Ovarian Carcinoma Tumorigenesis and Progression Through RhoA Pathway.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology

Published: October 09, 2017

Showing 1-12 of 16

Last Updated: 09/26/2026